Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 82 entries
View as:

Concurrent Radiochemotherapy Plus Anlotinib for Locally Advanced Cervical Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04772001 Org: User:
Start: 03/12/21 End: 01/31/26 Due: 01/31/27

Application of Point-of-care Ultrasound in Rapid Assessment of Cardiac Arrest Patients

Phase: N/A Priority: Normal
NCT ID: NCT05859516 Org: User:
Start: 02/01/23 End: 06/30/24 Due: 06/30/25

Effect of Radiotherapy Concurrent of TTFields in Patients With Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT04902586 Org: User:
Start: 06/19/21 End: 07/19/22 Due: 07/19/23

Trained Immunity in Fungal Infection and Its Mechanism

Phase: N/A Priority: Normal
NCT ID: NCT06628544 Org: User:
Start: 09/01/20 End: 12/01/23 Due: 12/01/24

Etoposide Plus Cisplatin Compared With Temozolomide in Patients With Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT05694416 Org: User:
Start: 02/01/23 End: 03/01/25 Due: 03/01/26

Fluorescence Imaging With Indocyanine Green(ICG) in Endoscopic Spinal Surgery

Phase: N/A Priority: Normal
NCT ID: NCT05808140 Org: User:
Start: 04/11/23 End: 12/31/25 Due: 12/31/26

Effects of Acupoint Massage Around Eyes on Ocular Biological Indexes

Phase: N/A Priority: Normal
NCT ID: NCT06293196 Org: User:
Start: 09/01/23 End: 06/30/25 Due: 06/30/26

The Neuro-epigenetics Biomarkers of Postoperative Delirium in Elderly Patients Undergoing Hip/Knee Replacement

Phase: N/A Priority: Normal
NCT ID: NCT04923243 Org: User:
Start: 11/03/21 End: 06/30/24 Due: 06/30/25

Safety and Efficacy of NRG-103 Injection in the Treatment of Recurrent Glioblastoma Patients

Phase: N/A Priority: Normal
NCT ID: NCT06757153 Org: User:
Start: 12/19/24 End: 12/31/27 Due: 12/31/28

CXCR4 Targeted PET Imaging in APA Preoperative Localization Diagnosis

Phase: N/A Priority: Normal
NCT ID: NCT05839483 Org: User:
Start: 05/30/23 End: 12/31/24 Due: 12/31/25

Analysis of Ocular Complications of AIDS Patients in Ophthalmic Consultation

Phase: N/A Priority: Normal
NCT ID: NCT06250881 Org: User:
Start: 10/01/23 End: 03/28/24 Due: 03/28/25

The Usefulness of CaIMR in Patients With STEMI

Phase: N/A Priority: Normal
NCT ID: NCT04984915 Org: User:
Start: 05/15/22 End: 12/01/23 Due: 12/01/24

Detection of G-quadruplex DNA Methylation in Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06537063 Org: User:
Start: 04/30/24 End: 12/30/24 Due: 12/30/25

Clinical Study on the Immune Response Characteristics of Novel Coronavirus and Influenza Virus Infection

Phase: N/A Priority: Normal
NCT ID: NCT06667063 Org: User:
Start: 09/19/24 End: 06/30/25 Due: 06/30/26

Clinical Features and Visual Prognosis of Infectious Endophthalmitis

Phase: N/A Priority: Normal
NCT ID: NCT06755177 Org: User:
Start: 06/01/24 End: 11/11/24 Due: 11/11/25

The Accuracy of Targeted Lymph Node Dissection of Non-small Cell Lung Cancer Patients According to Predictive Models

Phase: N/A Priority: Normal
NCT ID: NCT06768853 Org: User:
Start: 01/01/25 End: 12/31/26 Due: 12/31/27

Clinical Study of MAK Immune Cells in the Treatment of PHC

Phase: N/A Priority: Normal
NCT ID: NCT05242757 Org: User:
Start: 01/01/21 End: 03/31/22 Due: 03/31/23

Radiotherapy with Immunotherapy and Anti-Angiogenic Therapy for Advanced HER2-Negative Breast Cancer: a Single-Arm Study

Phase: N/A Priority: Normal
NCT ID: NCT06890871 Org: User:
Start: 08/08/24 End: 12/31/25 Due: 12/31/26

Bicarbonated Ringer's Solution Versus Lactated Ringer's Solution in Patients With Septic Shock

Phase: N/A Priority: Normal
NCT ID: NCT04449757 Org: User:
Start: 07/01/20 End: 05/30/21 Due: 05/30/22

Integrin αvβ6-targeted PET in Malignant Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05835570 Org: User:
Start: 01/01/23 End: 12/30/25 Due: 12/30/26

The Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (SYS6006) as Heterologous Booster in Participants Aged 18 Years and Older Vaccinated With Inactivated SARS-CoV-2 Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT05492643 Org: User:
Start: 08/13/22 End: 03/01/23 Due: 03/01/24

Cytoreductive Surgery(CRS) Plus Hyperthermic Intraperitoneal Chemotherapy(HIPEC) With Lobaplatin in Advanced and Recurrent Epithelial Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03371693 Org: User:
Start: 09/30/17 End: 03/30/23 Due: 03/30/24

Cisplatin Plus Temozolomide Compared With Temozolomide in Patients With MGMT Promotor Unmethylated Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT06186440 Org: User:
Start: 01/01/24 End: 01/01/25 Due: 01/01/26

Mechanism of Nitric Oxide on Ventilator-induced Diaphragm Dysfunction with Extracorporeal Membrane Lung Assistance

Phase: N/A Priority: Normal
NCT ID: NCT06660784 Org: User:
Start: 01/16/24 End: 12/30/25 Due: 12/30/26

MA+AZA Regimen for the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)

Phase: N/A Priority: Normal
NCT ID: NCT06345365 Org: User:
Start: 01/18/24 End: 12/31/28 Due: 12/31/29